R

Regulus Therapeutics
D

RGLS

1.24000
USD
-0.04
(-3.13%)
مغلق
حجم التداول
9,584
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
81,220,166
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARWR
    0.540
    (2.84%)
    19.560 USD
    A
    AXSM
    -1.870
    (-1.99%)
    91.870 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    D
    DVAX
    0.065
    (0.53%)
    12.445 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    F
    FOLD
    0.07000
    (0.75%)
    9.43000 USD
    I
    IONS
    -0.820
    (-2.54%)
    31.440 USD
    S
    SRPT
    1.070
    (0.91%)
    118.040 USD
    V
    VKTX
    0.130
    (0.40%)
    32.640 USD
    X
    XLRN
    0
    (0%)
    0 USD
    المزيد
الأخبار
المقالات

العنوان: Regulus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.